Suzetrigine: A novel nonopioid systemic analgesic
- 2 February 2026
- journal article
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 93 (2) , 94-98
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Unrelieved pain and risk of opioid use disorder or overdose in older adults prescribed opioidsPain, 2025
- Suzetrigine, a Non-Opioid NaV1.8 Inhibitor for Treatment of Moderate-to-Severe Acute Pain: Two Phase 3 Randomized Clinical TrialsAnesthesiology, 2025
- Selective Inhibition of Na V 1.8 with VX-548 for Acute PainNew England Journal of Medicine, 2023
- Status of peripheral sodium channel blockers for non-addictive pain treatmentNature Reviews Neurology, 2020
- Basic pharmacology of local anaestheticsBJA Education, 2020
- Enhanced Recovery After Surgery ProtocolsAnnals of Surgery, 2019
- Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adultsCochrane Database of Systematic Reviews, 2018
- Sodium channels and nociception: recent concepts and therapeutic opportunitiesCurrent Opinion in Pharmacology, 2008
- Diversity of Expression of the Sensory Neuron-Specific TTX-Resistant Voltage-Gated Sodium Ion Channels SNS and SNS2Molecular and Cellular Neuroscience, 2000
- A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neuronsNature, 1996